The angucycline antibiotics 1,2 are characterized by containing the modified benz [a]anthraquinone chromophore and show antimicrobial, antitumor and/or enzyme-inhibitory activities. Streptomyces sp. 2238-SVT4 produced four angucyclines, hatomarubigins A, B, C and D (Figure 1a) , which enhanced the cytotoxicity of colchicine in multidrug-resistant tumor cells. 3 Recently, we identified the hrb gene cluster as consisting of hatomarubigin biosynthesis genes belonging to Streptomyces sp. 2238-SVT4. 4 Several genes in the hrb cluster showed no homology to angucycline biosynthesis genes as previously reported. To clarify the function of hrb genes, biosynthetic intermediates of hatomarubigins were searched for in the culture extract. Colorguided fractionation resulted in the isolation of a new metabolite, hatomarubigin E (1). Herein, we report the isolation, structure elucidation and enzymatic conversion of 1.
The angucycline antibiotics 1,2 are characterized by containing the modified benz [a] anthraquinone chromophore and show antimicrobial, antitumor and/or enzyme-inhibitory activities. Streptomyces sp. 2238-SVT4 produced four angucyclines, hatomarubigins A, B, C and D (Figure 1a) , which enhanced the cytotoxicity of colchicine in multidrug-resistant tumor cells. 3 Recently, we identified the hrb gene cluster as consisting of hatomarubigin biosynthesis genes belonging to Streptomyces sp. 2238-SVT4. 4 Several genes in the hrb cluster showed no homology to angucycline biosynthesis genes as previously reported. To clarify the function of hrb genes, biosynthetic intermediates of hatomarubigins were searched for in the culture extract. Colorguided fractionation resulted in the isolation of a new metabolite, hatomarubigin E (1). Herein, we report the isolation, structure elucidation and enzymatic conversion of 1.
TLC and HPLC analyses detected a new metabolite in the 2-day culture of Streptomyces sp. 2238-SVT4 (Figure 2a) . The fermentation broth (2.0 l) was centrifuged and the mycelium was extracted with acetone. The extract was concentrated to a small volume and then extracted with ethyl acetate. After evaporation, the residue was applied to a silica gel column and eluted with hexane-chloroform (1:1). The eluate was purified by reversed-phase HPLC (YMC-Pack D-ODS-7, YMC, Kyoto, Japan) with 80% methanol. A single-peak fraction was concentrated to dryness to give an orange powder of 1 (4.7 mg).
The molecular formula of 1 was established as C 19 H 16 O 5 by highresolution FAB-MS. The 13 C-and 1 H-NMR data of 1 resembled those of hatomarubigin C (2), except for a methoxy group in 2 (Table 1 ). All one-bond 1 H-13 C connectivities were confirmed by the HMQC 5 spectrum. The COSY and HMBC 6 spectra of 1 revealed a proton spin network from a hydroxyl proton (d 4.73) through 1-H, 2-H 2 and 3-H to 4-H 2 and 3-CH 3 (Figure 1b) , and the presence of a 1,2,3,4-tetrasubstituted benzene ring. 1 H-13 C long-range correlations joined the two partial structures as shown in Figure 1b . A quinone carbonyl (C-7) was attached to C-6a from a coupling between 6-H and C-7. HMBCs from two phenolic hydroxyl protons (d 12.95 and 12.92) and two overlapping aromatic protons (d 7.29) to six aromatic carbons required them to be in a 2,3-disubstituted hydroquinone ring. Downfield chemical shifts for the two phenolic hydroxyl protons indicated a hydrogen-bonded arrangement of two quinone carbonyls constructing an anthraquinone framework (Figure 1b) . These results established the structure of 1 as 8-O-demethylhatomarubigin C.
In the hrb cluster, hrbU shows homology to an O-methyltransferase gene involved in tetracenomycin C biosynthesis. 7, 8 To confirm the function of hrbU, the recombinant protein expressed in Escherichia coli was tested for its ability to convert 1. HPLC analysis showed that 1 was converted to 2 by HrbU using S-(5¢-adenosyl)-L-methionine as a cofactor ( Figure 2b ). This result indicated that 1 is a biosynthetic intermediate of 2 and a substrate of HrbU O-methyltransferase.
Hatomarubigins A-D possess a methoxy group at the 8-position. HrbU is a candidate for O-methyltransferase, as judged from its homology to TcmO O-methyltransferase in tetracenomycin biosynthesis. 7, 8 A new metabolite designated as hatomarubigin E is an appropriate tool for identification of the function of hrbU. Purified protein encoded by hrbU converted hatomarubigin E to hatomarubigin C in the presence of S-(5¢-adenosyl)-L-methionine. This reaction corresponds to the 8-O-methylation step in hatomarubigin biosynthesis. HrbU contains a conserved motif for S-(5¢-adenosyl)-L-methionine binding (DVGGARG). [9] [10] [11] Our recent work has identified HrbY as a methylene-bridge-forming enzyme, which can convert hatomarubigin C to hatomarubigin D. 4 The combined results establish the last two steps in hatomarubigin biosynthesis.
EXPERIMENTAL PROCEDURE Fermentation of hatomarubigin E
The seed medium consisted of 1.0% soluble starch, 1.0% molasses, 1.0% Polypepton and 1.0% meat extract (pH 7.2). Seed tubes containing 7.5 ml of the medium were inoculated with a stock culture of Streptomyces sp. 2238-SVT4 maintained on a Bennett's agar slant and were incubated on a reciprocal shaker at 27 1C for 3 days. The seed culture at 2% was transferred to 500-ml Erlenmeyer flasks containing 100 ml of a medium consisting of 2.5% soluble starch, 1.5% soybean meal, 0.2% dry yeast and 0.4% calcium carbonate (pH 6.2 before sterilization). The fermentation was carried out on a rotary shaker at 27 1C for 2-5 days. The fermentation broth was centrifuged and the mycelium was extracted with acetone. After evaporation, the aqueous concentrate was extracted with ethyl acetate. The extract was dissolved in methanol and the metabolites were examined by reversed-phase HPLC (YMC-Pak R-ODS-7, YMC, Kyoto, Japan) with 80%. 
Physico-chemical properties of hatomarubigin E

Spectroscopic measurements
Mass spectra were obtained on a JMS-SX102A spectrometer (JEOL, Akishima, Japan) in the FAB mode using m-nitrobenzyl alcohol as matrix and polyethylene glycol as internal standard. UV and IR spectra were measured on UV-1700 (Shimadzu, Kyoto, Japan) and FT/IR-410 (JASCO, Hachioji, Japan) spectrometers, respectively. NMR spectra were obtained in CDCl 3 on a JEOL JNM-LA400 spectrometer with 1 H-NMR at 400 MHz and with 13 C-NMR at 100 MHz. Chemical shifts are given in p.p.m. relative to CHCl 3 at 7.24 p.p.m. for 1 H-NMR and CDCl 3 at 77.0 p.p.m. for 13 C-NMR.
Cloning and expression of hrbU
Streptomyces sp. 2238-SVT4 was used for the production of hatomarubigin E and the cloning of the hrbU gene. E. coli XL1-blue MRF' and the plasmid pGEM-11Z were used for the cloning experiment. E. coli M15 and pQE30 were used for expression of the O-methyltransferase gene. Restriction enzymes were obtained from Takara Bio Inc. (Otsu, Japan). T4 DNA ligase was obtained from Nippon Gene (Toyama, Japan). Transformation of E. coli with plasmid DNA by electroporation was performed under standard conditions using a Gene Pulser II electroporation system (Bio-Rad, Hercules, CA, USA). Other general procedures were performed as described by Sambrook et al. 12 The hrbU gene (1.1 kb) was amplified from Streptomyces sp. 2238-SVT4 genomic DNA using primers with additional BamHI and HindIII sites (5¢-CGCGGATCCGCTGACCAATCGCCCGAGACGCAG-3¢ and 5¢-ACCAAGCTT TCAGGCGTCCTTGTGGCCGATGAC-3¢). BamHI/HindIII-digested pQE30 and hrbU were ligated and introduced into E. coli M15, which was cultured in 500-ml Erlenmeyer flasks containing 100 ml of LB medium with kanamycin (25 mg ml À1 ) and ampicillin (100 mg ml À1 ). After isopropyl-b-D-thiogalactopyranoside (0.1 mM) was added, the culture was incubated at 18 1C for 20 h on a rotary shaker. The cells collected by centrifugation were washed and suspended in 100 ml of 50 mM Tris-HCl (pH 7.0)-5 mM dithiothreitol, followed by sonication on ice. The extract was centrifuged and the supernatant was applied to a nickel-nitrilotriacetic acid agarose column equilibrated with 50 mM Tris-HCl (pH 7.0), 10 mM imidazole and 5 mM dithiothreitol. The column was washed with 50 mM Tris-HCl (pH 7.0), 20 mM imidazole and 5 mM dithiothreitol, and eluted with 50 mM Tris-HCl (pH 7.0), 250 mM imidazole and 5 mM dithiothreitol. This fraction showed a single band at 37 kDa on SDSpolyacrylamide gel electrophoresis (15%). Protein concentration in the eluent was determined by Protein Assay Kit (Bio-Rad, Hercules, CA, USA).
Conversion of hatomarubigin E
The reaction mixture (500 ml) consisted of 50 mM hatomarubigin E, 50 mg ml À1 purified HrbU protein, 200 mM S-(5¢-adenosyl)-L-methionine chloride, 5 mM MgCl 2 , 15% dimethyl sulfoxide, 5 mM dithiothreitol and 100 mM Tris-HCl (pH 7.0). After the mixture was stirred at 30 1C for 14 h, the solution was extracted with ethyl acetate and concentrated. The residue was dissolved in 150 ml of dimethyl sulfoxide and analyzed by HPLC using a YMC-Pack R-ODS-7 column with 80% methanol at a flow rate of 1.0 ml/min. Visible absorption peaks for hatomarubigins C and E were detected at 465 nm. 
